10 Ankylosing Spondylitis Clinical Trials in Sun City, AZ (2026)

Q: How do I join a clinical trial in Sun City?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Sun City research site will contact you.

Recruiting Ankylosing Spondylitis Studies in Sun City

NCT07282665Recruiting

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile) vaccine is in decreasing the number of C. difficile infections (pCDI) in adult...

Sun City, AZPHASE332,000 participantsPfizer

View Study Details

NCT07177352Recruiting

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies....

Sun City, AZPHASE313,000 participantsHoffmann-La Roche

View Study Details

NCT04477785Recruiting

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biolo...

Sun City, AZ4,500 participantsMichael J. Fox Foundation for Parkinson's Research

View Study Details

NCT07165028Recruiting

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

The main purpose of the SYNERGY-OUTCOMES study is to find out whether retatrutide and tirzepatide can prevent major adverse liver outcomes (MALO) in people with high-risk metabolic dysfunction-associa...

Sun City, AZPHASE34,500 participantsEli Lilly and Company

View Study Details

NCT03507257Recruiting

Longitudinal Early-onset Alzheimer's Disease Study Protocol

The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) is a non-randomized, natural history, non-treatment study designed to look at disease progression in individuals with early onset cogniti...

Sun City, AZ850 participantsIndiana University

View Study Details

NCT07169578Recruiting

A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to mild dementia due to...

Sun City, AZPHASE3800 participantsHoffmann-La Roche

View Study Details

NCT07284784Recruiting

A Study of Buntanetap in Participants With PD

This study will examine the long-term safety of buntanetap in participants with PD. This will be a 36-month open-label safety study. This study will be conducted with two cohorts. Cohort 1 will enroll...

Sun City, AZPHASE2500 participantsAnnovis Bio Inc.

View Study Details

NCT07482176Recruiting

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

This is a multi-center, randomized, double-masked, active-comparator-controlled, Phase 3 study in a broad participant population (treatment-naïve and treatment-experienced) with neovascular (wet) age-...

Sun City, AZPHASE3284 participantsAdverum Biotechnologies, Inc.

View Study Details

NCT07113522Recruiting

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the saf...

Sun City, AZPHASE2140 participantsMirador Therapeutics, Inc.

View Study Details

NCT06944522Recruiting

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Study BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of bemdaneprocel in approximately 102 adults with Parkinson's Disease...

Sun City, AZPHASE3102 participantsBlueRock Therapeutics

View Study Details

About Ankylosing Spondylitis Clinical Trials in Sun City

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 10 ankylosing spondylitis clinical trials recruiting participants in Sun City, AZ. These studies are seeking a combined 56,676 participants. Research is being sponsored by Pfizer, Hoffmann-La Roche, Michael J. Fox Foundation for Parkinson's Research and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Sun City — FAQ

Are there ankylosing spondylitis clinical trials in Sun City?

Yes, there are 10 ankylosing spondylitis clinical trials currently recruiting in Sun City, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sun City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sun City research site will contact you about next steps.

Are clinical trials in Sun City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sun City studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 10 active trials in Sun City are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 21, 2026 from ClinicalTrials.gov